- Home
- WWW vs IDYA Comparison
WWW vs IDYA Comparison
Compare WWW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWW
- IDYA
- Stock Information
- Founded
- WWW 1883
- IDYA 2015
- Country
- WWW United States
- IDYA United States
- Employees
- WWW N/A
- IDYA N/A
- Industry
- WWW Shoe Manufacturing
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- WWW Consumer Discretionary
- IDYA Health Care
- Exchange
- WWW Nasdaq
- IDYA Nasdaq
- Market Cap
- WWW 2.2B
- IDYA 2.3B
- IPO Year
- WWW N/A
- IDYA 2019
- Fundamental
- Price
- WWW $26.00
- IDYA $29.96
- Analyst Decision
- WWW Buy
- IDYA Buy
- Analyst Count
- WWW 6
- IDYA 17
- Target Price
- WWW $29.67
- IDYA $48.20
- AVG Volume (30 Days)
- WWW 1.7M
- IDYA 1.3M
- Earning Date
- WWW 11-05-2025
- IDYA 11-04-2025
- Dividend Yield
- WWW 1.53%
- IDYA N/A
- EPS Growth
- WWW N/A
- IDYA N/A
- EPS
- WWW 1.04
- IDYA N/A
- Revenue
- WWW $1,821,400,000.00
- IDYA $7,000,000.00
- Revenue This Year
- WWW $7.52
- IDYA $90.17
- Revenue Next Year
- WWW $6.57
- IDYA $219.42
- P/E Ratio
- WWW $25.17
- IDYA N/A
- Revenue Growth
- WWW N/A
- IDYA N/A
- 52 Week Low
- WWW $9.58
- IDYA $13.45
- 52 Week High
- WWW $32.80
- IDYA $32.67
- Technical
- Relative Strength Index (RSI)
- WWW 44.73
- IDYA 63.91
- Support Level
- WWW $26.13
- IDYA $28.17
- Resistance Level
- WWW $27.73
- IDYA $31.07
- Average True Range (ATR)
- WWW 0.98
- IDYA 1.43
- MACD
- WWW 0.14
- IDYA 0.10
- Stochastic Oscillator
- WWW 44.98
- IDYA 77.89
About WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.